Evaluation of a Patient-Centered Decision-Making Support Tool for Older Adults With Advanced Breast Cancer and Their Care Partners
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 65 Years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
Not stated in the study description — ask the study team about visits and procedures.
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study tests whether a tool to help with care decisions is practical to use. It is for adults age 65 or older with breast cancer that has spread to other parts of the body and their care partners.
The purpose of this study is to determine the feasibility for a patient centered decision-making support tool for older adults with metastatic breast cancer and their care partners.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- Patients must have metastatic breast cancer, which means it has spread to other parts of the body.
- Patients must be age 65 or older.
- Patients must be getting or considering starting cancer treatment that works throughout the body.
- Patients and care partners must speak and read English because the tool is only offered in English.
- Patients and care partners must be able to give informed consent, meaning they understand the study and agree to join.
- Care partners must be age 18 or older.
- Patients must give spoken permission for their chosen care partner to join.
Who can't join
- Patients with early-stage breast cancer cannot join.
- Patients diagnosed with any cancer other than metastatic breast cancer cannot join.
- Care partners cannot join without the patient's spoken permission.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Inclusion Criteria: Patient Inclusion Criteria: 1. A diagnosis of metastatic breast cancer 2. Age 65 or older 3. Currently receiving systemic treatment for metastatic breast cancer or considering a plan to initiate systemic treatment for metastatic breast cancer 4. Able to speak and read English (because the Manta Cares platform is presently only offered in English only) 5. Able to provide informed consent Care Partner Inclusion Criteria: 1. Age 18 or older 2. Able to speak and read English (because the Manta Cares platform is presently only offered in English only) 3. Able to provide informed consent 4. Verbal permission from patient to enroll their designated care partner Exclusion Criteria: Patient Exclusion Criteria: 1. Early-stage breast cancer 2. Diagnosis of any other cancer besides metastatic breast cancer Care Partner Exclusion Criteria: 1\. Verbal permission from patient to enroll care partner not received.
Study sites (1)
NY
- University of Rochester · Rochester, NY 14620More trials in Rochester